Current Liabilities
Accrued Expenses and Other Liabilities at Fair Value
Morgan Stanley Accrued Expenses and Other Liabilities at Fair Value increased by 28.2% to $217.36B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27.8%, from $170.01B to $217.36B. Over 5 years (FY 2020 to FY 2025), Accrued Expenses and Other Liabilities at Fair Value shows relatively stable performance with a 1.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
Metric ID:
accrued_liabilities_fair_valueHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $169.07B | $169.96B | $158.33B | $176.58B | $149.97B | $162.64B | $154.44B | $170.76B | $147.04B | $150.30B | $151.51B | $152.84B | $155.02B | $152.24B | $153.76B | $170.01B | $171.35B | $162.41B | $169.57B | $217.36B |
| QoQ Change | — | +0.5% | -6.8% | +11.5% | -15.1% | +8.4% | -5.0% | +10.6% | -13.9% | +2.2% | +0.8% | +0.9% | +1.4% | -1.8% | +1.0% | +10.6% | +0.8% | -5.2% | +4.4% | +28.2% |
| YoY Change | — | — | — | — | -11.3% | -4.3% | -2.5% | -3.3% | -2.0% | -7.6% | -1.9% | -10.5% | +5.4% | +1.3% | +1.5% | +11.2% | +10.5% | +6.7% | +10.3% | +27.8% |
Range$147.04B – $217.36B
CAGR+5.4%
Avg YoY Growth+2.0%
Median YoY Growth-0.3%
Current Streak2 quarters growth
Accrued Expenses and Other Liabilities at Fair Value at Other Companies
Frequently Asked Questions
- What is Morgan Stanley's accrued expenses and other liabilities at fair value?
- Morgan Stanley (MS) reported accrued expenses and other liabilities at fair value of $217.36B in Q1 2026.
- How has Morgan Stanley's accrued expenses and other liabilities at fair value changed year-over-year?
- Morgan Stanley's accrued expenses and other liabilities at fair value increased by 27.8% year-over-year, from $170.01B to $217.36B.
- What is the long-term trend for Morgan Stanley's accrued expenses and other liabilities at fair value?
- Over 5 years (2020 to 2025), Morgan Stanley's accrued expenses and other liabilities at fair value has grown at a 1.5% compound annual growth rate (CAGR), from $157.63B to $169.57B.